Invesco Ltd. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$135,000
-60.4%
38,695
+14.5%
0.00%
Q3 2018$341,000
+39.8%
33,803
+0.3%
0.00%
Q2 2018$244,000
+73.0%
33,696
+44.1%
0.00%
Q1 2018$141,000
-24.6%
23,389
+20.0%
0.00%
Q4 2017$187,000
-97.0%
19,489
-97.2%
0.00%
-100.0%
Q3 2017$6,251,000
+12.6%
703,962
+60.4%
0.00%0.0%
Q2 2017$5,553,000
+1.9%
438,964
-15.4%
0.00%0.0%
Q1 2017$5,452,000
+12.9%
518,698
-1.1%
0.00%0.0%
Q4 2016$4,827,000
-10.6%
524,708
+14.6%
0.00%0.0%
Q3 2016$5,397,000
-5.5%
457,739
+3.7%
0.00%0.0%
Q2 2016$5,709,000
-7.9%
441,211
+13.7%
0.00%
-33.3%
Q1 2016$6,202,000
-41.0%
387,890
+5.7%
0.00%
-25.0%
Q4 2015$10,506,000
-71.2%
366,963
-71.4%
0.00%
-73.3%
Q3 2015$36,468,000
+5.4%
1,281,371
+33.1%
0.02%
+7.1%
Q2 2015$34,587,000
+97.0%
962,903
+218.9%
0.01%
+100.0%
Q1 2015$17,554,000
+18.5%
301,972
-14.1%
0.01%
+16.7%
Q4 2014$14,813,000
+15.6%
351,359
+6.3%
0.01%
+20.0%
Q3 2014$12,813,000
+15.2%
330,411
-7.2%
0.01%
+25.0%
Q2 2014$11,124,000
-29.7%
356,203
-6.7%
0.00%
-33.3%
Q1 2014$15,825,000
+96.3%
381,974
+83.4%
0.01%
+100.0%
Q4 2013$8,061,000
-6.8%
208,239
-15.8%
0.00%
-25.0%
Q3 2013$8,649,000247,1780.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders